Moleculin Biotech, Inc. (MBRX) vs Exicure, Inc. (XCUR)
- Moleculin Biotech, Inc. MBRX 0.28 −24.32%
- Exicure, Inc. XCUR 1.11 −0.89%
Moleculin Biotech, Inc. and Exicure, Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and Exicure, Inc. are of similar size ($7.6M and $7.3M). Exicure, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 10 metrics below, Exicure, Inc. leads on 6 and Moleculin Biotech, Inc. on 4.
Valuation
Profitability
| Metric | MBRX | XCUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 80.08% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,471.05%) | (168.37%) | (56.36%) |
| Return on assets | (152.41%) | (54.98%) | (48.04%) |
| Return on invested capital | (417.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack